Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
This study has been completed.
Study NCT00000854 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: November 2, 1999 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
HIV Wasting Syndrome
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Infection
Syndrome
Wasting Syndrome
Weight Loss
More general conditions related to this trial
Body Weight
Body Weight Changes
Disease
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Metabolic Diseases
Nutrition Disorders
Pathologic Processes
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Signs and Symptoms
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Nandrolone decanoate
Additional drug interventions recognized in this trial
Nandrolone
Nandrolone phenpropionate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Back to top of Main Content
